Lower SPRYD4 expression has been previously linked to lower survival in cancer [114] while higher levels of its encoded protein, SPRY-domain containing protein 4, are suggested to inhibit tumour growth through apoptosis [115]. This evidence concerns the gene SPRYD4 and neoplasm.